InterCure Statistics
Total Valuation
InterCure has a market cap or net worth of $45.37 million. The enterprise value is $90.56 million.
Important Dates
The last earnings date was Thursday, April 30, 2026, after market close.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
InterCure has 51.41 million shares outstanding. The number of shares has increased by 18.12% in one year.
| Current Share Class | 54.68M |
| Shares Outstanding | 51.41M |
| Shares Change (YoY) | +18.12% |
| Shares Change (QoQ) | +29.17% |
| Owned by Insiders (%) | 26.19% |
| Owned by Institutions (%) | 1.49% |
| Float | 37.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.54 |
| Forward PS | 0.21 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.82 |
| P/FCF Ratio | 9.97 |
| P/OCF Ratio | 8.59 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 19.89 |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.45.
| Current Ratio | 1.48 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | 12.32 |
| Interest Coverage | -1.28 |
Financial Efficiency
Return on equity (ROE) is -9.27% and return on invested capital (ROIC) is -4.83%.
| Return on Equity (ROE) | -9.27% |
| Return on Assets (ROA) | -2.19% |
| Return on Invested Capital (ROIC) | -4.83% |
| Return on Capital Employed (ROCE) | -5.36% |
| Weighted Average Cost of Capital (WACC) | 7.59% |
| Revenue Per Employee | $264,860 |
| Profits Per Employee | -$35,004 |
| Employee Count | 320 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.01 |
Taxes
| Income Tax | -2.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.05% in the last 52 weeks. The beta is 0.33, so InterCure's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -46.05% |
| 50-Day Moving Average | 0.80 |
| 200-Day Moving Average | 1.18 |
| Relative Strength Index (RSI) | 49.57 |
| Average Volume (20 Days) | 44,076 |
Short Selling Information
The latest short interest is 31,467, so 0.06% of the outstanding shares have been sold short.
| Short Interest | 31,467 |
| Short Previous Month | 7,624 |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.08% |
| Short Ratio (days to cover) | 0.77 |
Income Statement
In the last 12 months, InterCure had revenue of $84.76 million and -$11.20 million in losses. Loss per share was -$0.21.
| Revenue | 84.76M |
| Gross Profit | 12.77M |
| Operating Income | -8.00M |
| Pretax Income | -13.83M |
| Net Income | -11.20M |
| EBITDA | -2.62M |
| EBIT | -8.00M |
| Loss Per Share | -$0.21 |
Full Income StatementBalance Sheet
The company has $14.64 million in cash and $56.07 million in debt, with a net cash position of -$41.43 million or -$0.81 per share.
| Cash & Cash Equivalents | 14.64M |
| Total Debt | 56.07M |
| Net Cash | -41.43M |
| Net Cash Per Share | -$0.81 |
| Equity (Book Value) | 124.33M |
| Book Value Per Share | 2.42 |
| Working Capital | 32.11M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $5.28 million and capital expenditures -$1.11 million, giving a free cash flow of $4.55 million.
| Operating Cash Flow | 5.28M |
| Capital Expenditures | -1.11M |
| Depreciation & Amortization | 5.87M |
| Net Borrowing | -9.98M |
| Free Cash Flow | 4.55M |
| FCF Per Share | $0.09 |
Full Cash Flow StatementMargins
Gross margin is 15.06%, with operating and profit margins of -9.44% and -13.22%.
| Gross Margin | 15.06% |
| Operating Margin | -9.44% |
| Pretax Margin | -16.32% |
| Profit Margin | -13.22% |
| EBITDA Margin | -3.10% |
| EBIT Margin | -9.44% |
| FCF Margin | 5.37% |
